VIA Pharmaceuticals viapharmaceuticals.com


Public lists: Pharma Startups (4743)

Drug development company targeting vascular inflammation. Using proprietary drug assessment tools, the company has established a screening system to identify drug candidates. VIA acquires anti-inflammatory drugs that were clinically tested for other indications and directs their development in the cardiovascular secondary prevention setting. In June 2007, VIA completed a merger with Coratus Genetics, a publicly traded biotech company, to form Via Pharmaceuticals, Inc. (NASDAQ:VIAP).

Drug development company targeting vascular inflammation. Using proprietary drug assessment tools, the company has established a screening system to identify drug candidates. VIA acquires anti-inflammatory drugs that were clinically tested for other...Show all

Company (Alive / Active)

Phone: 415-283-2200

Fax:

750 Battery Street
Suite 330
San Francisco, 94111
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
VIA Pharmaceuticals $35M Mar 9, 2009
Sequel Pharmaceuticals $24.4M Sep 20, 2010
PlantForm Corporation $0M Apr 19, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related VIA Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Board Members

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque Aug 07, 2006 Feb 24, 2009 Patent